Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?

Archives of Gynecology and Obstetrics

Volumn 277, Issue 5, 2008, Pages 411-414

  Pirimoglu, Zehra Meltem ^a,b   Afsin, Yasemin ^a   Guzelmeric, Kadir ^a   Yilmaz, Muberra ^a   Unal, Orhan ^a   Turan, Mehmet Cem ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Borderline epithelial ovarian tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY TUMOR; PARAAORTIC LYMPH NODE; SALPINGOOOPHORECTOMY; TUMOR BIOPSY; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RETROPERITONEAL SPACE; TREATMENT OUTCOME;

EID: 41549134423     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-007-0478-2     Document Type: Article

References (27)

1. Taylor HC Jr (1929) Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 48:204-230
2. Staging announcement (1986) FIGO cancer committee. Gynecol Oncol 25:383-385
3. Serov SF, Scully RE, Sobin LH (1973) International histological typing of ovarian tumour, 9, histological typing of ovarian tumours. World Health Organization, Geneva
4. Seidman JD, Soslow RA, Vang R et al (2004) Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 35:918-933
5. Bell DA, Longacre TA, Prat J (2004) Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 35:934-948
6. Russell P (1984) Borderline tumors of the ovary. A conceptual dilemma. Clin Obstet Gynecol 11:259-277
7. Yazigi R, Sandstad J, Munoy AK (1998) Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 31:402-408
8. Leake JF, Rader JS, Woodruff JD, Rosenhein NB (1991) Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 42:124-130
9. Snider DB, Stuart GC, Nation JG, Robertson DI (1991) Evaluation of surgical staging in Stage 1 low malignancy potential ovarian tumors. Gynecol Oncol 40:129-132
10. Jones MB (2006) Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 49:517-525
11. Pecorelli S, Odicino F, Maisonneuve P et al (1998) FIGO annual report of the results of treatment in gynaecological cancer. Carcinoma of the ovary. J Epidemiol Biostat 3:75
12. Kaern J, Trope CG, Abeler VM (1993) A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospitl from 1970 to 1982. Cancer 71:1810-1820
13. Trimble CL, Trimble EL (1994) Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 55:52-61
14. Trimble CL, Trimble EL (2003) Ovarian tumors of low malignant potential. Oncology (Huntingt) 17:1563
15. Rota SM, Zanetta G, Iede N et al (1999) Clinical relevance of retroperitoneal involvement from epithelial ovarian tumors of borderline malignancy. Int J Gynecol Cancer 9:477-480
16. Morice P, Camatte S, Rey A et al (2003) Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol 14:592
17. Gershenson DM (2002) Is micropapillary serous carcinoma for real? Cancer 95:677
18. Kaern J, Trope CG, Kristensen GB, Abeler VM (1993) DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 3:349
19. Buttin BM, Herzog TJ, Powell MA, Rader JS (2002) Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 99:11
20. Sood AK, Abu-Rustum NR, Barakat RR et al (2005) Fifth international conference on ovarian cancer: challenges and opportunities. Gynecol Oncol 97:916
21. Geomini P, Bremer G, Kruitwagen R, Mol BW (2005) Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis. Gynecol Oncol 96:1
22. Boriboonhirusam D, Sermboon A (2004) Accuracy of frozen section in the diagnosis of malignant ovarian tumor. J Obstet Gyneacol Research 30:394-398
23. Boran N, Cil AP, Tulunay G et al (2005) Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97:845
24. Morice P, Camette S, El Hassan J et al (2001) Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 75:92
25. Suh-Burgmann E (2006) Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103:841
26. Zanetta G, Rota S, Chiari S et al (2001) Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 19:2658
27. NIH Consensus Conference (1995) Ovarian cancer: screening, treatment, and follow-up. JAMA 273:491